Last week, the Department of Health and Social Care issued further guidance for patients on access to medicines and treatments in a no-deal Brexit scenario.

The guidance is the first direct communication to patients about contingency planning. It states that the government has analysed the supply chain, made plans to reduce the risk of disruption, and given instructions to pharmaceutical companies to ensure that they have adequate stocks to cope with any potential delays at the border. It reiterates that the government is confident that if everyone does what they should do, the supply of medicines and other medical supplies will be uninterrupted in the event of exiting the EU without a deal.

Patient receiving medicine

Back to e-newsletter